Medicina
Departamento
Juan
Berenguer Berenguer
Publicaciones en las que colabora con Juan Berenguer Berenguer (86)
2023
-
Bictegravir/emtricitabine/tenofovir alafenamide in older individuals with HIV: Results of a 96-week, phase 3b, open-label, switch trial in virologically suppressed people ≥65 years of age
HIV Medicine, Vol. 24, Núm. 1, pp. 27-36
-
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2
Viruses, Vol. 15, Núm. 7
-
Recently acquired hepatitis C: Epidemiological characteristics and treatment response in a large cohort of MSM living with HIV in Madrid
Enfermedades Infecciosas y Microbiologia Clinica
2022
-
Discovering HIV related information by means of association rules and machine learning
Scientific Reports, Vol. 12, Núm. 1
-
Epidemiological trends of HIV/HCV coinfection in Spain, 2015–2019
HIV Medicine, Vol. 23, Núm. 7, pp. 705-716
-
Manejo de la infección por SARS-CoV-2 en urgencias
Revista Española de Urgencias y Emergencias, Vol. 1, Núm. 1, pp. 38-43
-
Predictors of low-level HIV viraemia and virological failure in the era of integrase inhibitors: A Spanish nationwide cohort
HIV Medicine, Vol. 23, Núm. 8, pp. 825-836
-
Progress in the quality of care for newly diagnosed people with HIV in Spain (2004–2019)
Antiviral Therapy, Vol. 27, Núm. 4
-
SARS-COV-2 Infection in People Living with HIV: Experience from a Tertiary Hospital in Madrid
AIDS Research and Human Retroviruses, Vol. 38, Núm. 5, pp. 394-398
-
Shorter Time to Discontinuation Due to Treatment Failure in People Living with HIV Switched to Dolutegravir Plus Either Rilpivirine or Lamivudine Compared with Integrase Inhibitor-Based Triple Therapy in a Large Spanish Cohort
Infectious Diseases and Therapy, Vol. 11, Núm. 3, pp. 1177-1192
-
Similar humoral immune responses against the SARS-CoV-2 spike protein in HIV and non-HIV individuals after COVID-19
Journal of Infection
2021
-
COVID-19 in hospitalized HIV-positive and HIV-negative patients: A matched study
HIV Medicine, Vol. 22, Núm. 9, pp. 867-876
-
Development and validation of a prediction model for 30-day mortality in hospitalised patients with COVID-19: The COVID-19 SEIMC score
Thorax, Vol. 76, Núm. 9, pp. 920-929
-
HCV eradication with IFN-based therapy does not completely restore gene expression in PBMCs from HIV/HCV-coinfected patients
Journal of Biomedical Science, Vol. 28, Núm. 1
-
Prevalence and factors associated with SARS-CoV-2 seropositivity in the Spanish HIV Research Network Cohort
Clinical Microbiology and Infection, Vol. 27, Núm. 11, pp. 1678-1684
-
Real world effectiveness of standard of care triple therapy versus two-drug combinations for treatment of people living with HIV
PloS one, Vol. 16, Núm. 4, pp. e0249515
-
Treatment with tocilizumab or corticosteroids for COVID-19 patients with hyperinflammatory state: a multicentre cohort study (SAM-COVID-19)
Clinical Microbiology and Infection, Vol. 27, Núm. 2, pp. 244-252
-
eGFR-EPI changes among HIV patients who switch from F/TDF to F/TAF while maintaining the same third agent in the Spanish VACH cohort
HIV Research and Clinical Practice, Vol. 22, Núm. 3, pp. 78-85
2020
-
2019 update of the European AIDS Clinical Society Guidelines for treatment of people living with HIV version 10.0
HIV Medicine, Vol. 21, Núm. 10, pp. 617-624
-
Autologous stem cell transplantation for lymphoma in HIV+ patients: higher rate of infections compared with non-HIV lymphoma
Bone Marrow Transplantation, Vol. 55, Núm. 9, pp. 1716-1725